Group 1 - The Hang Seng Index rose by 0.33%, gaining 79 points to reach 24,261 points, while the Hang Seng Tech Index fell by 0.33% [1] - Insurance funds continue to increase holdings in Chinese bank stocks, with institutions indicating significant valuation recovery potential for Hong Kong bank stocks [1] - Bank of Communications (01988) rose by 3.47%, China Everbright Bank (06818) increased by 1.86%, and Industrial and Commercial Bank of China (01398) gained 1.68% [1] - Three-Synch Pharmaceutical (01530) surged over 11% to a new high after reaching a significant licensing agreement with Pfizer, with strong ASCO data performance [1] - Innovent Biologics (01801) rose over 3.42%, with a year-to-date increase of over 120%, as Morgan Stanley anticipates further clinical catalysts to boost stock performance [1] - InnoCare Pharma-B (09606) increased by 13%, recently disclosing clinical data for DB-1310, attracting attention from international pharmaceutical giants [1] - China Rare Earth (00769) surged over 17%, following a 60% increase in trading volume, with positive signals for rare earth exports [1] - Pop Mart International (09992) rose by 2.47%, continuing to set historical highs, with its Labubu brand gaining global popularity [1] - Airline stocks continued their recent upward trend, benefiting from falling oil prices and the appreciation of the Renminbi, with institutions optimistic about airline profitability [1] - Air China (00753) rose by 4.5%, China Eastern Airlines (00670) increased by 4.42%, China Southern Airlines (01055) gained 4.18%, and BOC Aviation (02588) rose by 3.42% [1] Group 2 - Zhi Zi Cheng Technology (09911) rose over 7%, approaching historical highs, as the company plans to establish its global headquarters in Hong Kong, with institutions optimistic about future profit margin improvement [2] - Dekang Agriculture and Animal Husbandry (02419) increased by 4.97% to a new high, with the company reporting sales of 869,400 pigs in May, drawing market attention to industry capacity regulation progress [2] - Shide Global (00487) surged nearly 140%, as Australia’s Crown Resorts expressed interest in acquiring the property where the Sixteen Piers Casino is located [2]

Summary of Dekang Agriculture and Animal Husbandry Conference Call Company Overview - Dekang Agriculture and Animal Husbandry has achieved a compound annual growth rate (CAGR) of 59% over the past four years, ranking first among the top ten pig farming companies in China [2][3] - The company plans to reach a slaughter volume of 11 million pigs by 2025, potentially becoming the only listed pig farming company to exceed this threshold during the period from 2022 to 2025 [2][3] Core Business Model - Dekang employs an innovative "Company + Farmers" model, extending the breeding process to sows, which significantly reduces capital requirements and increases farmer returns, achieving a return on investment of 17%, well above the industry average [2][4][6] - The company has a production structure where self-breeding, first farm (piglet breeding), and second farm (sow breeding) account for 20%, 60%, and 20% of slaughter volume, respectively [4][5] Cost Efficiency and Competitive Advantage - Dekang has achieved a complete cost of less than 12.5 yuan per kilogram, significantly lower than the industry average of over 1 yuan per kilogram [7][12] - The feed-to-meat ratio has improved from 2.52 in 2021 to 2.48 in 2023, consistently below the industry average [11] - The company’s self-bred quality breeding pigs have national-leading performance, contributing to cost reduction and strengthening competitive advantages [11][12] Growth Potential and Market Strategy - Dekang's slaughter growth rate from 2019 to 2024 is projected at 60%, making it one of the fastest-growing listed companies [8][9] - The company anticipates that the number of breeding sows will support capacity expansion to 30 million pigs, with a regional strategy enhancing market attractiveness [8][9][15] - The company is targeting a slaughter volume of 15 million pigs by 2026, representing a 36% year-on-year growth [16] Financial Performance and Valuation - As of June 4, 2025, Dekang's market valuation is approximately 2,038 yuan per pig, which is below the average for leading companies in the A-share market [10][17] - The proportion of shares held through the Hong Kong-Shanghai Stock Connect has increased from 1.5% to 13.4% since 2024, indicating improved liquidity [10][17] Health Management and Technological Innovation - Dekang employs advanced health management practices, including comprehensive disease tracking and environmental design to enhance biosecurity [14] - The company has invested in digital management and health management technologies, which have proven effective during challenges such as the African swine fever outbreak [13][14] Conclusion - Dekang Agriculture and Animal Husbandry is positioned for strong future growth, supported by its innovative business model, cost efficiency, and strategic market expansion plans [15][16]

Group 1 - As of June 3, a total of 105 stocks reached their 52-week highs, with Huayin International Holdings (00989), Dingyifeng Holdings (00612), and Youquhui Holdings (02177) leading the high rate at 57.26%, 37.93%, and 23.02% respectively [1] - The closing prices and highest prices for the top three stocks are as follows: Huayin International Holdings at 1.370 and 1.950, Dingyifeng Holdings at 0.770 and 0.800, and Youquhui Holdings at 3.550 and 3.580 [1] - Other notable stocks that reached their 52-week highs include China Antibody-B (03681) with a high rate of 21.62% and Fengcheng Holdings (02295) at 19.52% [1] Group 2 - The report also lists stocks that reached their 52-week lows, with Des Holdings (08437) showing the largest decline at -38.79%, followed by Dimi Life Holdings (01667) at -20.50% [3] - The closing prices and lowest prices for the top three stocks that reached their lows are: Des Holdings at 0.177 and 0.071, Dimi Life Holdings at 0.140 and 0.128, and Lujizhi Technology (01745) at 0.197 and 0.194 [3] - Other stocks with significant declines include GBA Group (00261) at -11.48% and Baide International (02668) at -10.88% [3]

Market Overview - The Hang Seng Index closed down 1.2% at 23,289.77 points, with a total turnover of HKD 271.56 billion. The Hang Seng Tech Index fell 2.48% to 5,170.43 points. For the month, the Hang Seng Index rose 5.29% [1] - Current valuations of the Hang Seng Index are considered moderately low, while the Hang Seng Tech Index is at historical lows, indicating high investment value in the Hong Kong stock market [1] Blue Chip Performance - CSPC Pharmaceutical Group (01093) led blue-chip stocks, rising 6.3% to HKD 8.1, contributing 6.53 points to the Hang Seng Index. The company is in discussions for three potential licensing collaborations, with total payments potentially reaching USD 5 billion [2][4] - Other notable blue-chip movements include Li Auto-W (02015) up 3.79%, CK Infrastructure Holdings (01038) up 2.11%, while BYD Electronic (00285) and Tingyi (00322) saw declines of 6.03% and 5.01% respectively [2] Sector Movements - Large tech stocks generally declined, with Alibaba down 3.56% and Tencent down 2.41%. Apple-related stocks also faced significant drops, with Cowell e Holdings (01478) down 6.61% [3][5] - The automotive sector continued its downward trend, with Xpeng Motors-W (09868) down 5.04% and Great Wall Motors (02333) down 3.03%. Price competition in the automotive industry is expected to intensify [6] Pharmaceutical Sector - The pharmaceutical sector saw gains, with China Antibody-B (03681) up 21.31% and other biotech stocks also performing well. The upcoming ASCO conference is expected to boost interest in innovative drugs [3][4] Notable Stock Movements - Dekang Agriculture (02419) reached a new high, rising 14.15% due to leading industry cost advantages [7] - Sany International (00631) reported a revenue increase of 14.6% year-on-year, with a net profit increase of 23.2% [8] - New World Development (00017) saw a 3.9% increase, with contract sales reaching HKD 24.8 billion, exceeding 95% of its annual target [9] - Li Auto-W (02015) reported a revenue of RMB 25.93 billion for Q1 2025, a 1.1% year-on-year increase [10] - Hand Return Group (02621) experienced a significant drop of 18.19% on its first trading day [11]

Group 1 - The Hang Seng Index fell by 0.55%, down 131 points, closing at 23,695 points, while the Hang Seng Tech Index decreased by 0.66% [1] - The early trading volume in Hong Kong stocks reached HKD 1,076 million [1] - Robot-related stocks were active, with DCH Holdings (00179) rising nearly 6% and SUTENG (02498) increasing over 2% due to the upcoming CMG World Robot Competition [1] Group 2 - Eucan Vision Bio-B (01477) surged over 18% after OT-703 was approved for real-world research in Boao, Hainan [2] Group 3 - Smoore International (06969) rose over 5% as Glo Hilo is set to launch in Japan, with positive feedback from the trial market for heated non-combustible products [3] - Youjia Innovation (02431) increased over 5% after its L4 autonomous driving minibus received project designation, following a series of product showcases at the Shanghai Auto Show [3] Group 4 - Maanshan Iron & Steel (00323) saw a rise of over 7% as the steel industry showed improving performance in Q1, with institutions noting a marginal improvement in the sector's fundamentals [4] - InnoCare Pharma (02577) surged over 15% due to a partnership with NVIDIA for the next-generation 800V power architecture, drawing attention to third-generation semiconductors [4] Group 5 - Gu Ming (01364) increased by 4.5%, reaching a new high, with expectations of being included in the Hong Kong Stock Connect next month and a projected net increase of over 2,000 stores for the year [5] Group 6 - Dekang Agriculture and Animal Husbandry (02419) rose over 7%, with stock prices hitting a new high as institutions are optimistic about the company's valuation recovery potential [6] Group 7 - Gome Retail (06808) saw an early rise of nearly 7%, reporting a turnaround with a profit of RMB 410 million for the year, while Dehong Capital will promote the development of various store formats [7] - New Town Development (01030) fell over 3% amid reports of plans to issue guaranteed bonds domestically, aiming to raise RMB 1.5 to 2 billion [7] - Alibaba Health (00241) dropped over 4%, despite a year-on-year profit increase of over 62%, with analysts stating that profits did not meet expectations [7]

Core Viewpoint - CICC maintains the earnings forecast for Dekang Animal Husbandry (02419) and raises the target price by 57% to HKD 66, indicating a 15% upside potential from the current price, while maintaining an outperform rating for the industry [1] Group 1: Business Model - Dekang adopts a "company + farmer" model and has pioneered the second farm sow breeding model, implementing a strategy to densify in the southwestern region [2] - The company is projected to have a slaughter volume of 8.78 million in 2024 and 11 million in 2025, ranking fourth among listed pig companies and sixth in the industry [2] - The asset per head for Dekang is estimated at RMB 1,537, compared to RMB 2,317 for industry leaders, with the second farm's return on assets (ROA) at 17% in the first half of 2023 [2] Group 2: Cost Advantage - Dekang leads the industry in cost efficiency, with total costs projected to be below RMB 14.0 and RMB 12.5 per kilogram in 2024 and Q1 2025, respectively, compared to the industry average of RMB 15.0-15.5 and RMB 13.0-13.5 [3] - The low cost is attributed to technological empowerment in breeding and feed nutrition, as well as strict health management and efficient digital management [3] - The company is expected to achieve a return on equity (ROE) of 38% in 2024, the highest among listed pig companies [3] Group 3: Growth Potential - Dekang's slaughter volume CAGR from 2020 to 2024 is 59%, the highest among the top ten pig companies, with a forecast of reaching 11 million heads in 2025 [4] - The company is expected to maintain strong growth momentum, supported by a model that combines penetration potential and expansion capability, with a projected capacity of 30 million heads in the long term [4] Group 4: Valuation - Dekang's current valuation remains low, with an estimated market value of RMB 1,365 per head, indicating a potential increase of 39% compared to the industry average and 78% compared to Muyuan [5] - The company's fundamentals are improving liquidity, with an average turnover rate of 1% and an average daily trading volume of RMB 50 million as of May 19 [5]

Group 1 - The Hang Seng Index fell by 0.25%, down 59 points, closing at 23,581 points, while the Hang Seng Tech Index decreased by 0.62% [1] - Hong Kong's stock market saw a trading volume of HKD 110.1 billion in the morning session [1] Group 2 - BYD Co., Ltd. (01211) increased by 3.53%, with new energy vehicle sales in the first four months rising by 46.98% year-on-year, surpassing Toyota in Singapore [2] - NetEase-S (09999) rose by 1.8% ahead of its quarterly report release and an annual product exhibition next week [2] - Weimob Group (02013) surged by 20% following the establishment of an e-commerce product department by WeChat, indicating potential in AI development and WeChat small store business [2] - Tencent Music Entertainment Group (01698) rose over 7% post-earnings, with a steady increase in ARPPU and a 22.8% year-on-year growth in net profit for the first quarter [2] - Yixin Group (02858) saw an intraday increase of over 7%, with financing amounts facilitated by its fintech platform rising by 56.5% year-on-year in the first quarter [2] - China Tobacco Hong Kong (06055) increased by over 7%, signing a contract with Mengkun to boost its duty-free cigarette business, with potential for resource integration within the China Tobacco system [2] - Junshi Biosciences (02696) rose by over 6% after granting Sandoz AG rights for the development, production, and commercialization of product HLX13 [2] - Bruker Corporation (00325) saw a 6.48% increase in early trading, with a recent surge in new product launches indicating potential for high growth [2] - Dekang Agriculture and Animal Husbandry (02419) increased by over 11%, reporting sales revenue of HKD 1.867 billion from live pig sales in April, leading the industry in per-head profitability [2] - Xindong Company (02400) rose over 6% with the international launch of "Yise" scheduled for June, expected to further drive performance growth [2] - Beike-W (02423) fell by 4.14%, with a quarterly report set to be disclosed today, and institutions remain cautious about its profit outlook [2] Group 3 - MicroPort Scientific Corporation-B (02252) fell by 3.63% after announcing a discounted placement to raise funds, with the controlling shareholder cashing out nearly HKD 470 million [3]

Financial Performance - The company achieved a revenue of approximately RMB 22.46 billion in 2024, representing a year-on-year growth of 39.0%[8]. - Net profit for the year was approximately RMB 4.20 billion, a significant recovery from a loss of RMB 1.99 billion in 2023[8]. - The company's revenue from the pig segment reached RMB 18,271.6 million in 2024, representing a year-on-year growth of 49.1% due to continuous technological empowerment and efficient team management[43]. - The overall revenue for 2024 was RMB 22,463.0 million, an increase of 39.0% from RMB 16,155.4 million in 2023, primarily driven by growth in the pig segment[50]. - The fair value profit before biological asset adjustment was RMB 3,297.4 million in 2024, compared to a loss of RMB 1,278.5 million in 2023, driven by increased pig prices and reduced production costs[42]. - The net profit after biological asset adjustment totaled RMB 4,201.7 million in 2024, a significant recovery from a net loss of RMB 1,992.1 million in 2023[42]. - The overall gross margin improved significantly from 0.7% in 2023 to 21.7% in 2024, attributed to rising pig prices and cost reduction measures[52]. - The sales cost for 2024 was RMB 17,597.7 million, a 9.7% increase from RMB 16,035.7 million in 2023, mainly due to increased pig sales volume[51]. - The EBITDA (before fair value adjustment) for 2024 was RMB 4,624.3 million, a significant increase from RMB 9 million in 2023[65]. Production and Sales - The company sold 8,544,396 heads of commercial pigs in 2024, with an average selling price of RMB 2,193 per head, compared to 6,659,735 heads sold in 2023 at RMB 1,832[8]. - The poultry segment, particularly yellow feathered chickens, sold 88,120,210 heads in 2024, maintaining an average price of RMB 36.1[8]. - The company sold approximately 88.12 million yellow feathered chickens in 2024, maintaining stable production capacity compared to the previous year[48]. - The poultry segment revenue was RMB 3,275.8 million in 2024, a year-on-year decrease of 1.7% due to slight declines in both price and sales volume[48]. Corporate Governance - The board of directors emphasizes maintaining high corporate governance standards to protect shareholder interests and enhance corporate value[87]. - The board consists of a balanced mix of executive and non-executive directors, ensuring strong independent judgment and oversight[92]. - The company has established an independent board evaluation mechanism to enhance board effectiveness and shareholder protection[103]. - The audit committee held three meetings during the reporting period and met with external auditors three times to review the company's financial reports and accounts[112]. - The company has established three committees: the audit committee, remuneration committee, and nomination committee, to oversee specific areas of the company's affairs[109]. Research and Development - The company has entered into a technical cooperation agreement with the Chinese Academy of Agricultural Sciences to enhance research and development capabilities[11]. - The management team consists of 186 R&D members, with about 60.8% holding a master's degree or higher, ensuring strong expertise in breeding, feed, nutrition, and health management[46]. - The company emphasizes talent as a fundamental driver, combining technology and management to foster innovation and growth[26]. Risk Management and Compliance - The company has a risk management and internal control system in place, which has been reviewed and deemed effective by the board during the reporting period[141]. - The company has implemented strict biosecurity measures to mitigate disease risks in livestock, ensuring no significant losses due to diseases in 2024[82]. - The company has adopted an anti-corruption policy to prevent internal corruption and bribery, with open internal reporting channels for employees[143]. Shareholder Engagement and Dividends - In 2024, the company plans to distribute cash dividends of approximately RMB 350 million to all shareholders[26]. - The company reported a proposed final dividend of RMB 0.90 per share for the year ending December 31, 2024, compared to no dividend in 2023, pending shareholder approval at the annual general meeting on April 22, 2025[172]. - The company emphasizes effective communication with shareholders through various channels, including annual general meetings and investor relations activities[155]. Sustainability and ESG Initiatives - The company is committed to investing in ESG initiatives, following national fertilizer reduction action plans to promote sustainable agricultural development[85]. - The company has established a comprehensive ESG policy and has not faced any significant fines or penalties related to health, safety, or environmental regulations during the reporting period[181]. Future Plans and Strategies - By 2025, the company aims to achieve new milestones through efficiency improvements, cost reductions, and high-quality development, while strictly controlling various risks[84]. - The company will enhance its disease prevention system and invest in biosecurity to improve breeding environment standards and response capabilities[84]. - The company will focus on expanding its market share and sales network in Sichuan, with Chengdu, Meishan, and Yibin as core bases[85].

Financial Performance - Total revenue for the year ended December 31, 2024, reached RMB 22,463,038 thousand, a significant increase of 39% compared to RMB 16,155,412 thousand in 2023[5] - The company reported a profit before tax of RMB 4,201,795 thousand for 2024, recovering from a loss of RMB 1,991,781 thousand in 2023[5] - The company achieved a gross profit of RMB 4,865,291 thousand in 2024, a substantial increase from RMB 119,673 thousand in 2023[7] - Basic and diluted earnings per share for 2024 were RMB 10.55, a recovery from a loss of RMB 4.88 per share in 2023[5] - The gross profit margin improved significantly from 0.7% in 2023 to 21.7% in 2024, mainly due to rising pig prices and cost reduction measures[64] - The company recorded a profit of RMB 3,297.4 million before fair value adjustments of biological assets in 2024, compared to a loss of RMB 1,278.5 million in 2023[70] - The EBITDA (before fair value adjustments) for 2024 was RMB 4,624.3 million, a significant increase from RMB 9 million in 2023[76] Revenue Breakdown - Sales of live pigs and related products reached RMB 18,271,557,000, up from RMB 12,254,966,000, representing a 49% growth[16] - The revenue from the pig segment in 2024 was RMB 18,271.6 million, representing a year-on-year growth of 49.1%, driven by technological empowerment and efficient team management[48] - The poultry segment revenue in 2024 was RMB 3,275.8 million, a decrease of 1.7% compared to the previous year, attributed to slight declines in both price and sales volume[57] - The auxiliary products segment generated revenue of RMB 915.7 million in 2024, reflecting a 61.4% year-on-year growth, driven by the expansion of slaughtering operations[60] Assets and Liabilities - The total assets less current liabilities increased to RMB 13,992,701 thousand in 2024, compared to RMB 9,243,612 thousand in 2023[8] - Cash and cash equivalents rose significantly to RMB 4,491,952 thousand in 2024, up from RMB 2,544,830 thousand in 2023[8] - The company's net assets were approximately RMB 8,585.3 million, up from RMB 3,855.1 million as of December 31, 2023, indicating a significant increase of 123.3%[81] - The company's net debt was approximately RMB 2,253.2 million as of December 31, 2024, a decrease of 59.1% from RMB 5,533 million as of December 31, 2023, resulting in a net debt to equity ratio of 26.2% compared to 143.5% in the previous year[81] Dividends and Shareholder Returns - The company declared a dividend of RMB 0.90 per share for the year 2024, marking a return to profitability[5] - The company proposed a final dividend of RMB 0.90 per share for the year ending December 31, 2024, compared to no dividend in 2023[32] - The company has proposed a final dividend of RMB 0.90 per share for the year ended December 31, 2024, subject to shareholder approval at the annual general meeting on April 22, 2025[103] Operational Highlights - The number of market pigs sold increased to 8,544,396 heads in 2024, up from 6,659,735 heads in 2023, representing a growth of approximately 28%[3] - Average selling price for market pigs rose to RMB 2,193 per head in 2024, compared to RMB 1,832 per head in 2023, reflecting an increase of about 20%[3] - The company’s vertical integration model in pig and poultry farming allows for high control over food quality and safety throughout the supply chain[35] - The company has established a dynamic raw material database for feed formulation, allowing for effective cost control amid rising raw material prices[52] - The company has implemented strict biosecurity measures to mitigate disease risks in livestock, which is critical for maintaining production capacity and consumer confidence[94] Employee and Compensation - Employee costs increased to RMB 1,559,226,000 in 2024, up 33% from RMB 1,174,243,000 in 2023[22] - The total number of employees increased to 10,475 as of December 31, 2024, from 9,854 in 2023, reflecting a growth in workforce to support business operations[91] - Employee compensation totaled approximately RMB 1,559.2 million in 2024, an increase of 33% from RMB 1,174.2 million in 2023, aligning with market trends and performance[91] Future Outlook and Strategy - The company aims to achieve a new milestone by enhancing efficiency, reducing costs, and focusing on high-quality development in the pig farming sector, poultry sector, and auxiliary products sector by 2025[98] - The company plans to optimize pig farming scale and improve disease prevention systems to ensure a balanced supply and demand in the pig farming sector[99] - In the poultry sector, the company will develop innovative high-performance poultry breeds suitable for the southwestern market of China and strengthen customer relationships in the southern market to maintain profitability[99] - The company will continue to invest in ESG initiatives, including the "Hundred Villages, Million" project, to promote sustainable agricultural development[99] Governance and Compliance - The audit committee, consisting of three members, reviewed the annual performance and consolidated financial statements for the year ending December 31, 2024[115] - The audit firm KPMG confirmed that the figures in the preliminary performance announcement are consistent with the audited consolidated financial statements for the year[116] - The board expressed gratitude to customers, suppliers, and shareholders for their support and trust[123] - The board of directors includes both executive and independent non-executive members, ensuring a diverse governance structure[125]

Summary of Conference Call Records Company Overview - **Company**: 德康农牧 (DeKang Agriculture and Animal Husbandry) - **Industry**: Agriculture, specifically focused on pig farming and related operations Key Points and Arguments Business Model and Financial Performance - **Asset-Light Model**: 德康农牧 operates on a light asset model, which minimizes capital investment and leads to lower costs and higher returns on equity (ROE) [1][2] - **Cost Efficiency**: The company has achieved the lowest operational costs in the industry, with costs dropping significantly throughout the year. As of October, the total cost was reported to be below 12.9 RMB per kg [3][4] - **Production Growth**: The company has seen substantial growth in production, with output expected to reach approximately 870,000 heads this year, up from 1.3 million heads in 2020. Future projections estimate production of 1.1 to 1.2 million heads by 2025 [3][5] Market Position and Valuation - **Low Valuation**: 德康农牧's market capitalization is around 1.2 billion RMB, making it one of the lowest valued companies in the A+H share market. This low valuation, combined with strong fundamentals, suggests significant potential for valuation recovery [2][6] - **Growth Potential**: The company is positioned to capture further growth in the market, with a focus on high-quality growth rather than capital-intensive models [2][6] Cost Management and Future Outlook - **Cost Reduction Strategy**: The company has implemented a strategy to further reduce costs, with a target of achieving costs below 12.6 RMB per kg in the future. The management is confident in their ability to maintain cost efficiency while scaling production [4][5] - **Management Preparedness**: 德康农牧 is investing in management training and system improvements to prepare for future growth, aiming for production levels of 2 to 3 million heads in the long term [5][6] Financial Health - **Cash Flow and Debt Management**: The company has maintained a strong cash flow and a favorable debt structure, with a current asset-to-liability ratio improving significantly. As of October, cash reserves exceeded loans [6][8] - **Profitability**: The company reported a profitable situation with a selling price of approximately 18 RMB per kg against a cost of 12.9 RMB per kg, indicating a healthy profit margin [15][29] Industry Context - **Market Dynamics**: The overall market for pig farming is experiencing fluctuations, with supply and demand dynamics affected by seasonal changes and external factors such as weather conditions. The company anticipates a challenging market environment but remains optimistic about its cost advantages [28][30] - **Future Projections**: The company expects to maintain a competitive edge due to its low-cost structure and efficient management practices, projecting continued growth in production and profitability [29][36] Additional Important Information - **Management Changes**: The company is undergoing management reforms to enhance operational efficiency and prepare for future growth [5][6] - **Investment in Technology**: There is a focus on technological advancements in breeding and management processes to further improve productivity and cost efficiency [5][6] - **Long-term Planning**: The company has set ambitious long-term goals, including a target of 30 million heads by 2027, reflecting confidence in its growth strategy [8][9] This summary encapsulates the key insights from the conference call, highlighting the company's strategic focus, financial performance, and market positioning within the agricultural sector.